Clinical trial
The Discriminative Effects of Tramadol in Humans
NCT00499746 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00499746 |
|---|---|
| Title | The Discriminative Effects of Tramadol in Humans |
| Official title | Medications Development for Drug Abuse Disorders |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Opioid Abuse, Opioid Addiction, Stimulant Abuse, Stimulant Addiction |
| Intervention type | Drug |
| Interventions | tramadol, placebo, Hydromorphone, Methylphenidate |
| Enrollment | 20 |
| Start date | Nov 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Jul 11, 2007 |
| Last update posted | Oct 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: